NRG
55
-4
D
48
3
DGX
46
3
COST
44
-3
C
71
-10
URI
62
-3
FE
35
-2
STZ
47
2
AEP
61
2
WHR
57
-5
ICE
52
2
STX
73
-2
DHI
52
2
SNA
53
-2
JNJ
54
10
PSX
57
-7
VLO
56
-6
SLB
42
-2
AVGO
40
-2
LLY
68
4
NRG
55
-4
D
48
3
DGX
46
3
COST
44
-3
C
71
-10
URI
62
-3
FE
35
-2
STZ
47
2
AEP
61
2
WHR
57
-5
ICE
52
2
STX
73
-2
DHI
52
2
SNA
53
-2
JNJ
54
10
PSX
57
-7
VLO
56
-6
SLB
42
-2
AVGO
40
-2
LLY
68
4
Financhill
Back

Intensity Therapeutics 10K Form

Sell
16

INTS
Intensity Therapeutics

Last Price:
$0.33
Seasonality Move:
-27.87%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INTS News And Ratings

See the #1 stock for the next 7 days that we like better than INTS

INTS Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-2M
Price / Cash Flow: 0
Annual Sales: $0.02
Price / Book: 17.92

Profitability

EPS (TTM): -1.05000
Net Income (TTM): $-15M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Intensity Therapeutics Earnings Forecast

Key Intensity Therapeutics Financial Ratios

  • Per Share Earnings over the last 6 years have been positive in 2 years.

Intensity Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INTS
Website: intensitytherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INTS Technical Analysis vs Fundamental Analysis

Sell
16
Intensity Therapeutics (INTS) is a Sell

Is Intensity Therapeutics a Buy or a Sell?